Dexrazoxane as a Protective Agent in Anthracycline Treated Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Dexrazoxane hydrochloride|DRUG: Dexrazoxane hydrochloride
Sponsor: Fudan University